{"id":2925,"date":"2022-04-05T07:46:17","date_gmt":"2022-04-05T14:46:17","guid":{"rendered":"https:\/\/molecularf.wpenginepowered.com\/?p=2925"},"modified":"2026-09-18T17:52:13","modified_gmt":"2026-09-19T00:52:13","slug":"partenariat-avec-admare-bioinnovations","status":"publish","type":"post","link":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/","title":{"rendered":"Partenariat avec adMare BioInnovations"},"content":{"rendered":"\n<div class=\"et_pb_section_0 et_pb_section et_section_regular et_block_section\"><div class=\"et_pb_row_0 et_pb_row et_block_row\"><div class=\"et_pb_column_0 et_pb_column et_pb_column_2_3 et_block_column et_pb_css_mix_blend_mode_passthrough\"><div class=\"et_pb_text_0 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><h3><b>Molecular Forecaster Inc. collabore avec adMare BioInnovations sur les approches computationnelles de la d\u00e9couverte de m\u00e9dicaments<\/b><\/h3>\n<p><b>MONTR\u00c9AL, QU\u00c9BEC, 5 avril 2022<\/b> - Molecular Forecaster Inc. (MFI) est heureux d'annoncer un partenariat avec adMare BioInnovations (adMare) pour fournir des ressources de conception de m\u00e9dicaments assist\u00e9e par ordinateur (CDAO) \u00e0 des programmes de R&amp;D s\u00e9lectionn\u00e9s dans le pipeline d'adMare. Participant au programme d'acc\u00e9l\u00e9ration d'adMare destin\u00e9 aux jeunes entreprises qu\u00e9b\u00e9coises les plus prometteuses, MFI offre des logiciels et des services exclusifs pour la conception et la d\u00e9couverte de m\u00e9dicaments \u00e0 un stade pr\u00e9coce, ce qui permet de r\u00e9duire les co\u00fbts, d'accro\u00eetre les capacit\u00e9s et les comp\u00e9tences et d'acc\u00e9l\u00e9rer les programmes pharmaceutiques pr\u00e9cliniques.<\/p>\n<p>\"L'apport d'expertise scientifique est un \u00e9l\u00e9ment essentiel du mod\u00e8le d'adMare pour la cr\u00e9ation d'entreprises qui sont \u00e0 la base de l'industrie des sciences de la vie, solide et en pleine croissance au Canada\", d\u00e9clare Claudio Sturino, directeur principal de la chimie d'adMare. \"adMare compl\u00e8te son expertise interne en R&amp;D en s'associant \u00e0 des acteurs de l'\u00e9cosyst\u00e8me dot\u00e9s de capacit\u00e9s sp\u00e9cialis\u00e9es uniques, telles que les capacit\u00e9s innovantes en chimie computationnelle de MFI, l'une des entreprises ayant particip\u00e9 avec succ\u00e8s \u00e0 notre programme d'acc\u00e9l\u00e9ration. Nous sommes ravis de travailler avec cette entreprise \u00e9mergente qui continue \u00e0 se d\u00e9marquer dans ce domaine.\"<\/p>\n<p>MFI offre \u00e0 ses clients des logiciels et des services uniques pour acc\u00e9l\u00e9rer les diff\u00e9rentes \u00e9tapes du processus de d\u00e9couverte de m\u00e9dicaments. Les plates-formes logicielles sophistiqu\u00e9es et exclusives de l'entreprise peuvent \u00eatre utilis\u00e9es pour la d\u00e9couverte de m\u00e9dicaments, la pr\u00e9diction du m\u00e9tabolisme, la chimie combinatoire et la conception de catalyseurs asym\u00e9triques. En tant qu'organisme de recherche sous contrat sp\u00e9cialis\u00e9 dans la d\u00e9couverte de m\u00e9dicaments in silico, MFI dispose d'une connaissance et d'une exp\u00e9rience approfondies dans plusieurs disciplines, ce qui signifie que l'\u00e9quipe peut augmenter la capacit\u00e9 de ses clients sans avoir besoin d'ajouter des frais g\u00e9n\u00e9raux. L'approche sans droits de propri\u00e9t\u00e9 intellectuelle permet \u00e9galement \u00e0 MFI de soutenir facilement plusieurs projets et \u00e9quipes au sein d'une m\u00eame organisation, ce qui convient parfaitement \u00e0 adMare et \u00e0 un certain nombre de ses programmes.<\/p>\n<p>\"En tant que partenaire d'adMare dans le domaine de la chimie computationnelle, nous avons l'occasion de soutenir et de contribuer directement au secteur biotechnologique en pleine croissance du Canada, en rendant service \u00e0 une organisation qui a fait la m\u00eame chose pour nous\", d\u00e9clare Josh Pottel, pr\u00e9sident-directeur g\u00e9n\u00e9ral de MFI. \"Nous sommes fiers d'\u00eatre Canadiens, reconnaissants et membres actifs de l'\u00e9cosyst\u00e8me adMare, et enthousiastes \u00e0 l'id\u00e9e de soutenir d'autres entreprises \u00e9mergentes dans le domaine des sciences de la vie au sein de la communaut\u00e9 nationale des sciences de la vie.\"<\/p>\n<p>                                                                                                       <b>###<\/b><\/p>\n<p><b>\u00c0 propos de Molecular Forecaster Inc.<\/b><\/p>\n<p>Molecular Forecaster Inc. (MFI) est une soci\u00e9t\u00e9 de chimie computationnelle sp\u00e9cialis\u00e9e dans la d\u00e9couverte de m\u00e9dicaments, la m\u00e9canique quantique, la dynamique mol\u00e9culaire, la chimio-informatique et l'intelligence artificielle. Proposant des logiciels propri\u00e9taires, des algorithmes et des services de recherche contractuelle de pointe, MFI travaille avec des organisations qui cherchent \u00e0 acc\u00e9l\u00e9rer la d\u00e9couverte pr\u00e9clinique de m\u00e9dicaments, qu'il s'agisse de jeunes entreprises de biotechnologie ou d'entreprises pharmaceutiques bien \u00e9tablies. Fond\u00e9e en 2010, MFI est issue de recherches men\u00e9es \u00e0 l'Universit\u00e9 McGill et fait aujourd'hui partie du <a href=\"https:\/\/www.admarebio.com\/innovation-centre\/admare-accelerate-quebec-program\/\">programme Acc\u00e9l\u00e9ration Qu\u00e9bec<\/a> au sein du Centre de bioinnovations adMare \u00e0 Montr\u00e9al, Canada. <\/p>\n<p><b>\u00c0 propos d'adMare BioInnovations<\/b><\/p>\n<p>Riche de ses d\u00e9couvertes scientifiques, le Canada est pr\u00eat \u00e0 devenir un leader mondial dans le domaine des sciences de la vie. Pour que cela devienne une r\u00e9alit\u00e9, adMare utilise son expertise scientifique et commerciale, son infrastructure sp\u00e9cialis\u00e9e et son capital d'investissement pour cr\u00e9er de nouvelles entreprises, des \u00e9cosyst\u00e8mes solides et des talents pr\u00eats pour l'industrie - et r\u00e9investit dans l'industrie canadienne pour s'assurer qu'elle est soutenue \u00e0 long terme. Les 25 entreprises de notre portefeuille ont attir\u00e9 plus de 1,4 milliard de dollars d'investissements, ont une valeur combin\u00e9e de plus de 3 milliards de dollars et emploient plus de 900 Canadiens. L'adMare Academy a form\u00e9 plus de 500 anciens \u00e9l\u00e8ves, dont 95 % sont employ\u00e9s dans l'industrie canadienne des sciences de la vie.<\/p>\n<p><b>Contact presse<\/b><br \/>Rebecca Johnston <br \/>Puzzlewood Communication Inc.<br \/>T\u00e9l : +1.604.803.2184<\/p>\n<p><u>rebecca@puzzlewood.ca<\/u><\/p>\n<p><b>Contact pour le d\u00e9veloppement des affaires<\/b><br \/>Geoffrey Crampton<br \/>T\u00e9l. 1.514-265-4363<\/p>\n<p><u>geoff.crampton@molecularforecaster.com<\/u><\/p>\n<p>&nbsp;<\/p>\n<\/div><\/div><\/div><div class=\"et_pb_column_1 et_pb_column et_pb_column_1_3 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\"><div class=\"et_pb_image_0 et_pb_image et_pb_module et_block_module\"><span class=\"et_pb_image_wrap\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2024\/01\/admare_mfi.png\" width=\"431\" height=\"270\" srcset=\"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2024\/01\/admare_mfi.png 431w, https:\/\/molecularforecaster.com\/wp-content\/uploads\/2024\/01\/admare_mfi-300x188.png 300w, https:\/\/molecularforecaster.com\/wp-content\/uploads\/2024\/01\/admare_mfi-400x250.png 400w\" sizes=\"(max-width: 431px) 100vw, 431px\" class=\"wp-image-2913\" title=\"admare_mfi\" \/><\/span><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Molecular Forecaster Inc. (MFI) est heureux d&rsquo;annoncer un partenariat avec adMare BioInnovations (adMare) pour fournir des ressources de conception de m\u00e9dicaments assist\u00e9e par ordinateur (CADD) \u00e0 des programmes de R&amp;D s\u00e9lectionn\u00e9s dans le pipeline d&rsquo;adMare.<\/p>\n","protected":false},"author":4,"featured_media":4957,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"class_list":["post-2925","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Partenariat avec adMare BioInnovations - Molecular Forecaster<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Partenariat avec adMare BioInnovations - Molecular Forecaster\" \/>\n<meta property=\"og:description\" content=\"Molecular Forecaster Inc. (MFI) est heureux d&#039;annoncer un partenariat avec adMare BioInnovations (adMare) pour fournir des ressources de conception de m\u00e9dicaments assist\u00e9e par ordinateur (CADD) \u00e0 des programmes de R&amp;D s\u00e9lectionn\u00e9s dans le pipeline d&#039;adMare.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/\" \/>\n<meta property=\"og:site_name\" content=\"Molecular Forecaster\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-05T14:46:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-19T00:52:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2022\/04\/admare_mfi-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"431\" \/>\n\t<meta property=\"og:image:height\" content=\"270\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Oph\u00e9lie Rostaing\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@molforecaster\" \/>\n<meta name=\"twitter:site\" content=\"@molforecaster\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Oph\u00e9lie Rostaing\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/partenariat-avec-admare-bioinnovations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/partenariat-avec-admare-bioinnovations\\\/\"},\"author\":{\"name\":\"Oph\u00e9lie Rostaing\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#\\\/schema\\\/person\\\/4c3d29267a275c25cfde0a2cf0c2e536\"},\"headline\":\"Partenariat avec adMare BioInnovations\",\"datePublished\":\"2022-04-05T14:46:17+00:00\",\"dateModified\":\"2026-09-19T00:52:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/partenariat-avec-admare-bioinnovations\\\/\"},\"wordCount\":4,\"publisher\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/partenariat-avec-admare-bioinnovations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/molecularforecaster.com\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/admare_mfi-1.png\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/partenariat-avec-admare-bioinnovations\\\/\",\"url\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/partenariat-avec-admare-bioinnovations\\\/\",\"name\":\"Partenariat avec adMare BioInnovations - Molecular Forecaster\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/partenariat-avec-admare-bioinnovations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/partenariat-avec-admare-bioinnovations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/molecularforecaster.com\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/admare_mfi-1.png\",\"datePublished\":\"2022-04-05T14:46:17+00:00\",\"dateModified\":\"2026-09-19T00:52:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/partenariat-avec-admare-bioinnovations\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/partenariat-avec-admare-bioinnovations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/partenariat-avec-admare-bioinnovations\\\/#primaryimage\",\"url\":\"https:\\\/\\\/molecularforecaster.com\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/admare_mfi-1.png\",\"contentUrl\":\"https:\\\/\\\/molecularforecaster.com\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/admare_mfi-1.png\",\"width\":431,\"height\":270},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/partenariat-avec-admare-bioinnovations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Partenariat avec adMare BioInnovations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/\",\"name\":\"Molecular Forecaster\",\"description\":\"Research-as a-Service to create more certainty in drug discovery\",\"publisher\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#organization\",\"name\":\"Molecular Forecaster\",\"url\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/molecularforecaster.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/MFI_Logo.png\",\"contentUrl\":\"https:\\\/\\\/molecularforecaster.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/MFI_Logo.png\",\"width\":642,\"height\":260,\"caption\":\"Molecular Forecaster\"},\"image\":{\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/molforecaster\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/molecular-forecaster\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC3fJ27NvPDqtJ8BgcNApWwA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/#\\\/schema\\\/person\\\/4c3d29267a275c25cfde0a2cf0c2e536\",\"name\":\"Oph\u00e9lie Rostaing\",\"url\":\"https:\\\/\\\/molecularforecaster.com\\\/fr\\\/author\\\/orostaing\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Partenariat avec adMare BioInnovations - Molecular Forecaster","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/","og_locale":"fr_FR","og_type":"article","og_title":"Partenariat avec adMare BioInnovations - Molecular Forecaster","og_description":"Molecular Forecaster Inc. (MFI) est heureux d'annoncer un partenariat avec adMare BioInnovations (adMare) pour fournir des ressources de conception de m\u00e9dicaments assist\u00e9e par ordinateur (CADD) \u00e0 des programmes de R&amp;D s\u00e9lectionn\u00e9s dans le pipeline d'adMare.","og_url":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/","og_site_name":"Molecular Forecaster","article_published_time":"2022-04-05T14:46:17+00:00","article_modified_time":"2026-09-19T00:52:13+00:00","og_image":[{"width":431,"height":270,"url":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2022\/04\/admare_mfi-1.png","type":"image\/png"}],"author":"Oph\u00e9lie Rostaing","twitter_card":"summary_large_image","twitter_creator":"@molforecaster","twitter_site":"@molforecaster","twitter_misc":{"\u00c9crit par":"Oph\u00e9lie Rostaing"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/#article","isPartOf":{"@id":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/"},"author":{"name":"Oph\u00e9lie Rostaing","@id":"https:\/\/molecularforecaster.com\/fr\/#\/schema\/person\/4c3d29267a275c25cfde0a2cf0c2e536"},"headline":"Partenariat avec adMare BioInnovations","datePublished":"2022-04-05T14:46:17+00:00","dateModified":"2026-09-19T00:52:13+00:00","mainEntityOfPage":{"@id":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/"},"wordCount":4,"publisher":{"@id":"https:\/\/molecularforecaster.com\/fr\/#organization"},"image":{"@id":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/#primaryimage"},"thumbnailUrl":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2022\/04\/admare_mfi-1.png","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/","url":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/","name":"Partenariat avec adMare BioInnovations - Molecular Forecaster","isPartOf":{"@id":"https:\/\/molecularforecaster.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/#primaryimage"},"image":{"@id":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/#primaryimage"},"thumbnailUrl":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2022\/04\/admare_mfi-1.png","datePublished":"2022-04-05T14:46:17+00:00","dateModified":"2026-09-19T00:52:13+00:00","breadcrumb":{"@id":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/#primaryimage","url":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2022\/04\/admare_mfi-1.png","contentUrl":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2022\/04\/admare_mfi-1.png","width":431,"height":270},{"@type":"BreadcrumbList","@id":"https:\/\/molecularforecaster.com\/fr\/partenariat-avec-admare-bioinnovations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/molecularforecaster.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Partenariat avec adMare BioInnovations"}]},{"@type":"WebSite","@id":"https:\/\/molecularforecaster.com\/fr\/#website","url":"https:\/\/molecularforecaster.com\/fr\/","name":"Molecular Forecaster","description":"Research-as a-Service to create more certainty in drug discovery","publisher":{"@id":"https:\/\/molecularforecaster.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/molecularforecaster.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/molecularforecaster.com\/fr\/#organization","name":"Molecular Forecaster","url":"https:\/\/molecularforecaster.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/molecularforecaster.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2023\/12\/MFI_Logo.png","contentUrl":"https:\/\/molecularforecaster.com\/wp-content\/uploads\/2023\/12\/MFI_Logo.png","width":642,"height":260,"caption":"Molecular Forecaster"},"image":{"@id":"https:\/\/molecularforecaster.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/molforecaster","https:\/\/www.linkedin.com\/company\/molecular-forecaster\/","https:\/\/www.youtube.com\/channel\/UC3fJ27NvPDqtJ8BgcNApWwA"]},{"@type":"Person","@id":"https:\/\/molecularforecaster.com\/fr\/#\/schema\/person\/4c3d29267a275c25cfde0a2cf0c2e536","name":"Oph\u00e9lie Rostaing","url":"https:\/\/molecularforecaster.com\/fr\/author\/orostaing\/"}]}},"_links":{"self":[{"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/posts\/2925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/comments?post=2925"}],"version-history":[{"count":3,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/posts\/2925\/revisions"}],"predecessor-version":[{"id":6300,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/posts\/2925\/revisions\/6300"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/media\/4957"}],"wp:attachment":[{"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/media?parent=2925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/categories?post=2925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/molecularforecaster.com\/fr\/wp-json\/wp\/v2\/tags?post=2925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}